Aix-University of Marseille
Also known as: Aix Marseille Université | APHM | AP HM | AP-HM | APHM - AMU | APHM - Centre de Pharmacolgie Clinique et d'Evaluations Thérapeutiques | APHM Marseille | ASSIATANCE PUBLIQUE HOPITAUX DE MARSEILLE | Assistance Publique des Hopitaux de Marseille | ASSISTANCE PUBLIQUE DES HOPITAUX DE MARSEILLE | Assistance Publique des Hôpitaux de Marseille | Assistance Publique des Hôpitaux de Marseille (AP-HM) | Assistance Publique des Hôpitaux de Marseille - Pharmacometry department | Assistance Publique - Hôpitaux de Marseille | Assistance Publique-Hôpitaux de Marseille | Assistance Publique Hopitaux De Marseille | assistance publique hôpitaux de marseille | Assistance Publique - Hôpitaux de Marseille | Assistance Publique Hôpitaux de Marseille | Assistance Publique- Hôpitaux de Marseille | Assistance Publique-Hôpitaux de Marseille | ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE | ASSISTANCE PUBLIQUE HOPITAUX MARSEILLE | ASSISTANCE PUBLIQUE HÔPITAUX MARSEILLE | Assistance Publiques Hôpitaux de Marseille | ASSISTANCE PUBLQIUE HOPITAUX DE MARSEILLE | Assitance Publique - Hôpitaux de Marseille | Assitance Publique Hôpitaux de Marseille | Centre du Palais - Marseille - France | Centre Hospitalier La Timone | CHU de la Timone | CHU de Marseille | CHU la Timone, Marseille , France | CHU la Timone, Marseille, France | CHU La Timone, Marseille, France | CHU Marseille | CHU MARSEILLE | CHU Timone MARSEILLE | CHU Timone-MARSEILLE | Head of Neurology Department, UMR CRMBM CNRS 6612, Timone University Hospital, Marseille, France | Hôpital de la Timone (MARSEILLE) | HOPITAL NORD- MARSEILLE | HOPITAL TIMONE - MARSEILLE CEDEX 05 | HOPITAL TIMONES - MARSEILLE | Immunology Investigator, Cancerology Institut Marseille | INRA/INSERM/Université Aix-Marseille | Institut Marseille | La Timone Children Hospital, Marseilles | La Timone Hospital, Marseille | La Timone University Hospital | Marseille (FR), La Timone Children Hospital | Marseille North Hospital, France | Marseilles Public University | Marseille University Hospital | Samu of Marseille, France | SESSTIM (IRD, Inserm, Université Aix-Marseille) | Timone University | UMR1252 SESSTIM (INSERM, IRD, Aix Marseille Université) | University Hospital, Marseille | University of Marseille | University of Marseilles (APHM)
Highest phase reached
Phase 4
First clinical trial
May 1, 2001Last known activity
Jan 31, 2026
Timeline
1400s
- Jun 1, 1409
Aix-University of Marseille— Founded
Drugs by trial phase (164 distinct, 139 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (69 own, 0 via acquisition)
Phase 2 (43 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (24 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Lung Injury
- Adenocarcinoma
- Adrenal Insufficiency
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Atherosclerosis
- Atrial Fibrillation
- Blood Coagulation Disorders
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Bronchiectasis
- Brugada Syndrome
- Cancer Pain
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Cardiac Complexes, Premature
- Cardiovascular Diseases
- Charcot-Marie-Tooth Disease
- Chikungunya Fever
- Chondroma
- Chondrosarcoma
- Coinfection
- Collagen Diseases
- Colorectal Neoplasms
- Communicable Diseases
- Contracture
- Crohn Disease
- Diabetic Foot
- Disease Progression
- Dupuytren Contracture
- Erectile Dysfunction
- Esophageal Neoplasms
- Fibrosis
- Fistula
- Foot Ulcer
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Graves Disease
- Head and Neck Neoplasms
- Hemangiosarcoma
- Hematoma
- Hematoma, Subdural
- Hematoma, Subdural, Chronic
- Hematoma, Subdural, Intracranial
- Hemostatic Disorders
- Hereditary Sensory and Motor Neuropathy
- HIV Infections
- Hypogonadism
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infections
- Inflammation
- Intestinal Neoplasms
- Ischemia
- Kidney Diseases
- Kidney Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, Lymphoid
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Medulloblastoma
- Melanoma
- Meningioma
- Mesothelioma
- Monoclonal Gammopathy of Undetermined Significance
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Muscle Spasticity
- Neoplasm Metastasis
- Neoplasms
- Nephritis
- Nerve Compression Syndromes
- Neuroendocrine Tumors
- Osteoarthritis
- Osteoarthritis, Knee
- Osteosarcoma
- Pancreatic Neoplasms
- Paraproteinemias
- Pneumonia
- Pneumonia, Ventilator-Associated
- Pneumonia, Viral
- Polyneuropathies
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Progeria
- Psoriasis
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinoblastoma
- Rett Syndrome
Recent trials (50)
- NCT07052084OfficialPhase 3Jan 31, 2026
- NCT07052084Lead sponsorPhase 3Jan 31, 2026
- NCT06485908OfficialPhase 1/Phase 2Oct 31, 2024
- NCT06524583CollaboratorPhase 2Oct 31, 2024
- NCT06524583OfficialPhase 2Oct 31, 2024
- NCT06485908Lead sponsorPhase 1/Phase 2Oct 31, 2024
- NCT06349122Lead sponsorPhase 4Aug 31, 2024
- NCT06175377Lead sponsorN/AMar 30, 2024
- NCT06084637Lead sponsorPhase 3Feb 2, 2024
- NCT05857358Lead sponsorPhase 1/Phase 2Jan 31, 2024
- NCT05857371Lead sponsorPhase 2Nov 30, 2023
- NCT05571722Study directorPhase 4Apr 3, 2023
- NCT05571722Lead sponsorPhase 4Apr 3, 2023
- NCT05512403Overall official - principal investigatorPhase 3Jan 30, 2023
- NCT05501743Lead sponsorPhase 2Nov 30, 2022
Details
- Founded
- Marseilles, FR Jun 1, 1409
- Last known activity
- Jan 31, 2026